Changes of Peripapillary Capillary Density in Patients with Vogt–Koyanagi–Harada Disease Evaluated by Optical Coherence Tomography Angiography

Table 1

Demographic and clinical data of patients with VKH disease with or without optic disc swelling.

	Optic disc swelling group	Nonoptic disc swelling group	value
N	12	32	—
Sex (M/F)	6/6	17/15	0.853^a
Age ± SD, year	50.50 ± 9.64	43.84 ± 14.40	0.088^b
Interval between ocular symptom onset and initiation of treatment, median (interquartile range), days	29.00 (10.50, 31.50)	7.00 (5.25, 19.00)	0.003^c
Pretreatment IOP ± SD, mmHg	15.00 ± 1.89	14.68 ± 2.45	0.576^b
Post-treatment IOP ± SD, mmHg	15.27 ± 1.47	14.83 ± 2.22	0.367^b
Pretreatment BCVA (logMAR), median (interquartile range)	0.60 (0.33, 1.05)	0.65 (0.40, 0.90)	0.814^c
Post-treatment BCVA (logMAR), median (interquartile range)	0.10 (0.00, 0.28)	0.00 (0.00, 0.10)	0.053^c

SD standard deviation, IOP intraocular pressure, BCVA best-corrected visual acuity. ^aχ² test. ^bt test. ^cMann–Whitney U test.